TechGenesis Therapeutics Partners With Genentech For New AI-Focused Drug Discovery Project, Raising $52 Million! Genesis Therapeutics wants to put a theoretical molecule into a simulation. The tech giant now collaborates with Genentech!by Giuliano J. de Leon
Healthy Living/WellnessFDA Approves Genentech Drug Alecensa For ALK-Positive Lung Cancerby Katherine Derla
Healthy Living/WellnessExperimental Drug Ocrelizumab Proves Successful Against Hard-To-Treat Type Of Multiple Sclerosisby Ted Ranosa
Healthy Living/Wellness23andMe to Sell DNA Data of Parkinson's Customers to Genentech for $60 Millionby Rhodi Lee
Healthy Living/WellnessGenentech Submits New Drug Application for Cobimetinib with Zelboraf for Treating Advanced Melanomaby Dianne Depra
Healthy Living/WellnessSkin cancer drug by Roche meets goals during late-stage testingby Dianne Depra
Snapdragon 8 Elite Is Qualcomm's Answer to Apple's A18 Pro, Apple Intelligence, But Can It Rise Above?